Role of semaglutide in restoring ovulation in youth and adults with polycystic ovary syndrome (RESTORE Study)

Is this Study for You?

Let's Get Started!

Details
Age

Child to Adult

Eligibility

To be eligible: Female sex Age 12-35 years old Suspected or Diagnosed PCOS Periods more than 5 weeks apart Not desiring pregnancy in the next 18 months Not using hormonal birth control Struggle with weight Youth BMI >95th percentile Adults BMI >/=27 kg/m2 Contact: PCOSresearch@cuanschutz.edu

Type of Study

Treatment

Locations

Childrens Hospital Colorado
Outpatient CTRC

Principal Investigator
Photograph of Melanie Green,  MD, PhD

Melanie Green, MD, PhD

Study ID

Protocol Number: 21-4941

More information available at ClinicalTrials.gov: NCT05819853

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers